Leuprorelin/norethisterone acetate
Подписчиков: 0, рейтинг: 0
| Combination of | |
|---|---|
| Leuprorelin | Gonadotropin-releasing hormone agonist |
| Norethisterone acetate | Progestin |
| Clinical data | |
| Trade names | Lupaneta Pack |
| Other names | Leuprolide/norethindrone acetate |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| License data | |
| Routes of administration |
Intramuscular and by mouth |
| ATC code |
|
| Legal status | |
| Legal status |
|
Leuprorelin/norethisterone acetate, also known as leuprolide/norethindrone acetate and sold under the brand name Lupaneta Pack, is a co-packaged medication used to treat endometriosis. It contains leuprorelin as the acetate, a gonadotropin-releasing hormone agonist, and norethisterone acetate, a progestin. The leuprorelin is given by intramuscular injection and the norethisterone acetate is taken by mouth.
The co-packaged medication was approved for medical use in the United States in December 2012.
Medical uses
Leuprorelin/norethisterone acetate is indicated for the initial management of the painful symptoms of endometriosis and for management of recurrence of symptoms.
Further reading
- Surrey ES (2022). "GnRH agonists in the treatment of symptomatic endometriosis: a review". F&S Reports. doi:10.1016/j.xfre.2022.11.009.